Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -1.35% | 195.35 | 1.2% | $486.61m | |
| GILD | Gilead Sciences, Inc. | -1.56% | 71.21 | 0.9% | $439.27m | |
| BIIB | Biogen Inc. | -0.75% | 313.18 | 1.3% | $342.13m | |
| ILMN | Illumina, Inc. | -3.74% | 305.37 | 3.5% | $328.61m | |
| CELG | Celgene Corporation | -1.50% | 79.40 | 1.2% | $318.95m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.04% | 172.00 | 1.9% | $229.07m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.11% | 379.60 | 2.6% | $219.24m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.04% | 121.39 | 2.0% | $213.67m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.31% | 129.50 | 16.4% | $162.15m | |
| A | Agilent Technologies, Inc. | -3.84% | 61.81 | 1.5% | $148.97m | |
| BMRN | BioMarin Pharmaceutical Inc. | -4.48% | 98.89 | 4.4% | $133.13m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.21% | 178.95 | 23.3% | $114.41m | |
| EXAS | Exact Sciences Corporation | -2.09% | 60.95 | 25.3% | $103.37m | |
| ECYT | Endocyte, Inc. | -0.09% | 23.50 | 2.1% | $95.77m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.53% | 106.41 | 5.1% | $93.27m |
Company Profile
Blueprint Medicines Corp. engages in the research, development, and commercialization of pharmaceutical products. It focuses on medicines to improve the lives of patients with genomically defined cancers and rare diseases. Its portfolio includes BLU-285 and BLU-554 for the treatment of gastrointestinal stromal tumors, systemic mastocytosis, and leukemia. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.